Video

The PCR Song

John Tickle Walks on Custard

Newtonwin Fluid

GCTA

The Drug Song

It's Too Late to Apoptize

The Elements Song

Sweet Home Aparatus

Pharmacy Respect

Photosynthesis Rock! Take 2

Getting Drugs to Their Targets


Join Frank Szoka of UCSF School of Pharmacy to find out about the scientific basis for the delivery of drugs to selected sites in the body, why this field of knowledge is vital to optimizing clinical outcomes, and what to expect in the future. Series: "UCSF Mini Medical School for the Public" [3/2007] [Health and Medicine] [Show ID: 12124]

Humans vs Microbes: Who Will Win


2007 Wonderfest: Bay Area Festival of Science. David Schneider, Assistant Professor of Microbiology & Immunology, Stanford. Bob Siegel, Associate Professor of Microbiology & Immunology, Stanford

Drugs: One Size Does Not Fit All


August 9, 2007 presentation by Russ Altman for the Stanford University Office of Science Outreach's Summer Science Lecture Series. There are a number of causes for variation in drug response across the population, but differences in genetics are an important factor. Russ Altman, Professor & Chair of Bioengineering and Professor of Genetics and Medicine, discusses how variations in genetics can alter the "typical" response as well as touch upon the ethical issues with the use of this knowledge.

Drugs for Brain Tumours


Trudy Forte discusses her work developing nano-sized low-density lipoprotein (LDL) particles that can be used as a safe and effective means of delivering anticancer drugs to brain tumors, particularly the most common malignant brain tumor in adults and one of the deadliest forms of cancer. Series: "Lawrence Berkeley National Laboratory Summer Lecture Series" [11/2007] [Health and Medicine] [Science] [Show ID: 13002]

Genetic Engineering


Professor Saltzman introduces the elements of molecular structure of DNA such as backbone, base composition, base pairing, and directionality of nucleic acids. He describes the processes of DNA synthesis, transcription, RNA splicing, translation, and post-translational processing required to make a protein such as insulin from its genetic code (DNA). Professor Saltzman describes the genetic code. RNA interference is also discussed as a way to control gene expression, which can be applied as a new way to treat diseases.

Engineering New Approaches to Cancer Therapy


With his 500-plus patents, Robert Langer, Jr. surely has dibs on the title of MIT’s Mr. Wizard. This talk, which concludes the series on cancer research, deals with Langer’s efforts to design materials for safer and more effective cancer treatment.

Ali G-Science


Ali G talks to some geezers about science, and techmology.

Return to the RNAi World


While investigating the genetic workings of the microscopic worm, C. elegans, Mello and colleague Andrew Fire, PhD, of the Carnegie Institution of Washington, discovered RNAi, a natural but previously unrecognized process by which a certain form of RNA can be manipulated to silence—or interfere with—the expression of a selected gene. The discovery, published in the journal Nature in 1998, has had two extraordinary impacts on biological science. One is as a research tool: RNAi is now the state-of-the-art method by which scientists can knock out the expression of specific genes in cells, to thus define the biological functions of those genes.